Related Experiment Video
Updated: Apr 24, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Lipid-modifying treatments for heart failure: is their use justified?
John G F Cleland1, Kate Hutchinson2, Pierpaolo Pellicori2
1National Heart & Lung Institute, Royal Brompton & Harefield Hospitals, Imperial College, London UB9 6JH, UK.
Abstract:
Interventions for coronary artery disease in heart failure have not been successful. It seems unlikely that coronary events play no role in the progression of heart failure and the ultimate demise of the patient. Meta-analysis suggests no benefit of fibrates in cardiovascular disease or heart failure. Polyunsaturated fats have equal benefit in cardiovascular disease. Two large trials of statins found no effect on mortality, but one trial found a reduction in morbidity. Retrospective analyses suggest that patients with milder disease might retain the benefit observed with statins in patients with coronary disease who do not have heart failure. Differences among statins may exist.
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure VI: Adjunct Therapies
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cardiomyopathy V: Interprofessional Care
Heart Failure Drugs: Diuretics
